ArticlePain2019

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.